Prognostic value of albumin-based indices for mortality after heart failure: a systematic review and meta-analysis

Ji Jiang1, Ping Miao2, Gang Xin3

  • 1Emergency department, the Affiliated People's Hospital of Ningbo University, 251 Baizhang East Road, Ningbo, Zhejiang Province, China. newgo123456@163.com.

PubMed

Insights

Albumin-based indices like the albumin-bilirubin score (ABS) predict heart failure mortality. Other ratios also show predictive value, though data is limited.

Area of Science:

  • Cardiology
  • Biomarkers
  • Prognostics

Background:

  • Albumin-based indices are explored for predicting heart failure (HF) mortality.
  • This study investigates the predictive utility of several albumin ratios and the albumin-bilirubin score (ABS).

Purpose of the Study:

  • To evaluate the effectiveness of albumin-based indices in predicting mortality in heart failure patients.
  • To assess the prognostic value of albumin-globin ratio, lactate-albumin ratio, BUN-albumin ratio, fibrinogen-albumin ratio, and ABS.

Main Methods:

  • A systematic literature search was conducted across major databases (Embase, PubMed, Web of Science, Scopus).
  • A random-effect meta-analysis of multivariate adjusted data was performed to calculate pooled hazard ratios (HR) and 95% confidence intervals (CI).
  • Subgroup analyses were performed for short-term (<90 days) and long-term (≥1 year) mortality.

Main Results:

  • Meta-analysis included seven studies on ABS, three on BUN-albumin, three on fibrinogen-albumin, and two each on albumin-globulin and lactate-albumin ratios.
  • The albumin-bilirubin score (ABS) significantly predicted both short-term (HR: 2.01) and long-term (HR: 1.36) mortality in HF.
  • High fibrinogen-albumin ratio (HR: 1.12), BUN-albumin ratio (HR: 1.84), and lactate-albumin ratio (HR: 1.84) were also identified as predictors of HF mortality.

Conclusions:

  • The quality of evidence for albumin-based indices predicting HF mortality is very low.
  • The albumin-bilirubin score (ABS) independently predicts both short-term and long-term mortality after heart failure.
  • Other albumin ratios also show potential in predicting HF mortality, but require further investigation due to limited data.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
105
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Heart Failure V: Nursing Interventions01:30

Heart Failure V: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
2
Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5